• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大安大略省巨细胞动脉炎的发病率和患病率。

Incidence and prevalence of giant cell arteritis in Ontario, Canada.

机构信息

Department of Medicine, Western University, Schulich School of Medicine & Dentistry, London, Ontario, Canada.

Department of Medicine, St. Joseph's Health Care London, Ontario, Canada.

出版信息

Rheumatology (Oxford). 2020 Nov 1;59(11):3250-3258. doi: 10.1093/rheumatology/keaa095.

DOI:10.1093/rheumatology/keaa095
PMID:32249899
Abstract

OBJECTIVE

To estimate trends in the incidence and prevalence of GCA over time in Canada.

METHODS

We performed a population-based study of Ontario health administrative data using validated case definitions for GCA. Among Ontario residents ≥50 years of age we estimated the annual incidence and prevalence rates between 2000 and 2018. We performed sensitivity analyses using alternative validated case definitions to provide comparative estimates.

RESULTS

Between 2000 and 2018 there was a relatively stable incidence over time with 25 new cases per 100 000 people >50 years of age. Age-standardized incidence rates were significantly higher among females than males [31 cases (95% CI: 29, 34) vs 15 cases (95% CI: 13, 18) per 100 000 in 2000]. Trends in age-standardized incidence rates were stable among females but increased among males over time. Incidence rates were highest among those ≥70 years of age. Standardized prevalence rates increased from 125 (95% CI 121, 129) to 235 (95% CI 231, 239) cases per 100 000 from 2000 to 2018. The age-standardized rates among males rose from 76 (95% CI 72, 81) cases in 2000 to 156 (95% CI 151, 161) cases per 100 000 population in 2018. Between 2000 and 2018, the age-standardized rates among females similarly increased over time, from 167 (95% CI 161, 173) to 304 (95% CI 297, 310) cases per 100 000 population.

CONCLUSION

The incidence and prevalence of GCA in Ontario is similar to that reported in the USA and northern Europe and considerably higher than that reported for southern Europe and non-European populations.

摘要

目的

评估加拿大时间范围内巨细胞动脉炎(GCA)发病率和患病率的趋势。

方法

我们对安大略省的健康管理数据进行了基于人群的研究,使用了经过验证的 GCA 病例定义。在≥50 岁的安大略省居民中,我们估计了 2000 年至 2018 年的年发病率和患病率。我们使用替代的经过验证的病例定义进行了敏感性分析,以提供比较估计。

结果

在 2000 年至 2018 年期间,发病率相对稳定,每 10 万名≥50 岁人群中有 25 例新发病例。标准化发病率在女性中明显高于男性[2000 年为每 10 万人 31 例(95%CI:29,34),而男性为每 10 万人 15 例(95%CI:13,18)]。女性的标准化发病率趋势稳定,但随时间推移男性的发病率逐渐升高。发病率在≥70 岁的人群中最高。标准化患病率从 2000 年的 125(95%CI 121,129)例增加到 2018 年的 235(95%CI 231,239)例/10 万人。2000 年男性的标准化发病率从每 10 万人 76 例(95%CI 72,81)上升到 2018 年的 156 例(95%CI 151,161)例/10 万人。在 2000 年至 2018 年期间,女性的标准化发病率也随时间推移而增加,从每 10 万人 167 例增加到 304 例(95%CI 297,310)例。

结论

安大略省 GCA 的发病率和患病率与美国和北欧报道的相似,远高于南欧和非欧洲人群的报道。

相似文献

1
Incidence and prevalence of giant cell arteritis in Ontario, Canada.加拿大安大略省巨细胞动脉炎的发病率和患病率。
Rheumatology (Oxford). 2020 Nov 1;59(11):3250-3258. doi: 10.1093/rheumatology/keaa095.
2
Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.2015 年巨细胞动脉炎和风湿性多肌痛的当代流行率估计。
Semin Arthritis Rheum. 2017 Oct;47(2):253-256. doi: 10.1016/j.semarthrit.2017.04.001. Epub 2017 Apr 7.
3
Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.意大利北部26年间经活检证实的巨细胞动脉炎的发病率、患病率及生存率
Arthritis Care Res (Hoboken). 2017 Mar;69(3):430-438. doi: 10.1002/acr.22942.
4
Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway.挪威南部巨细胞动脉炎的发病趋势和死亡率。
Arthritis Care Res (Hoboken). 2021 Mar;73(3):409-414. doi: 10.1002/acr.24133.
5
Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.1972-2012 年挪威西部巨细胞动脉炎的发病率:一项回顾性队列研究。
Arthritis Res Ther. 2017 Dec 15;19(1):278. doi: 10.1186/s13075-017-1479-6.
6
Epidemiology of large vasculitis in Shanghai, China: A 10-year multicenter hospital-based study and systematic review.中国上海大血管炎的流行病学:一项为期 10 年的多中心基于医院的研究和系统评价。
Int J Rheum Dis. 2024 Oct;27(10):e15360. doi: 10.1111/1756-185X.15360.
7
Increased Mortality for Individuals With Giant Cell Arteritis: A Population-Based Study.巨细胞动脉炎患者死亡率升高:一项基于人群的研究。
Arthritis Care Res (Hoboken). 2022 Aug;74(8):1294-1299. doi: 10.1002/acr.24573. Epub 2022 May 24.
8
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.意大利北部大血管血管炎(巨细胞动脉炎和 Takayasu 动脉炎)的发病率和患病率:一项基于人群的研究。
Semin Arthritis Rheum. 2021 Aug;51(4):786-792. doi: 10.1016/j.semarthrit.2021.06.001. Epub 2021 Jun 7.
9
The incidence of giant cell arteritis in Ontario, Canada.加拿大安大略省巨细胞动脉炎的发病率。
Can J Ophthalmol. 2019 Feb;54(1):119-124. doi: 10.1016/j.jcjo.2018.03.002. Epub 2018 Nov 12.
10
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.西班牙西北部经活检证实的巨细胞动脉炎的流行病学:18年期间的趋势
Ann Rheum Dis. 2001 Apr;60(4):367-71. doi: 10.1136/ard.60.4.367.

引用本文的文献

1
The incidence of vasculitides in Israel from 2007 to 2021 and during the COVID-19 pandemic.2007年至2021年以及新冠疫情期间以色列血管炎的发病率。
Ther Adv Musculoskelet Dis. 2024 Oct 7;16:1759720X241274032. doi: 10.1177/1759720X241274032. eCollection 2024.
2
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.
3
Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study.
1999年至2019年美国原发性系统性血管炎死亡率的趋势和地理差异:一项基于人群的研究
J Clin Med. 2021 Apr 18;10(8):1759. doi: 10.3390/jcm10081759.
4
A meta-analysis of the epidemiology of giant cell arteritis across time and space.巨细胞动脉炎的时空流行病学荟萃分析。
Arthritis Res Ther. 2021 Mar 11;23(1):82. doi: 10.1186/s13075-021-02450-w.
5
One Giant Step for Giant Cell Arteritis: Updates in Diagnosis and Treatment.巨细胞动脉炎的一大步进展:诊断与治疗的最新进展
Curr Treat Options Neurol. 2021;23(2):6. doi: 10.1007/s11940-020-00660-2. Epub 2021 Jan 16.